Stantec (STN) Tops Q1 EPS by 27c ; Provides Outlook

Stantec (NYSE: STN) reported Q1 EPS of Cdn$0.90, Cdn$0.27 better than the analyst estimate of Cdn$0.63. Revenue for the quarter came in at Cdn$1.4 billion versus the consensus estimate of Cdn$996.56 million.

2024 Outlook

Stantec reaffirms its annual targets for 2024, included in the guidance released on February 28, 2024.

Net revenue growth - 11% to 15%
Adjusted diluted EPS growth - 12% to 16%
Adjusted EBITDA as % of net revenue - 16.2% to 17.2%

For earnings history and earnings-related data on Stantec (STN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c